You can unsubscribe at any time using the link at the bottom of any newsletter or contacting info@predictimmune.com
Stay up to date with the latest technology, conference and funding news from PredictImmune.
PredictImmune to exhibit and host symposium at the British Society of Gastroenterologists Annual Meeting 2019 this June in Glasgow, UK.
PredictImmune to exhibit and host symposium at the British Society of Gastroenterologists Annual Meeting 2019 this June in Glasgow, UK. Cambridge, UK, 3rd June 2019. Come along and hear Dr Miles Parkes and Dr Paul Lyons present an exciting sponsored symposium,...
PredictImmune exhibiting at its first major USA conference Digestive Disease Week (DDW) in San Diego, 18th – 21st May 2019
PredictImmune exhibiting at its first major USA conference Digestive Disease Week (DDW) in San Diego, 18 - 21 May 2019Cambridge, UK, 15th May 2019: Come along and learn about the new and potentially game-changing IBD prognostic, PredictSURE IBD™ at Digestive...
Gut publication extends follow-up for PredictImmune's blood-based prognostic biomarker in IBD.
Gut publication extends follow-up for PredictImmune's blood-based prognostic biomarker in IBD. Cambridge, UK, 2nd May 2019: Longer-term follow-up data published this week in Gut, by Professor Ken Smith's team at the University of Cambridge, provides further...
PredictImmune's first prognostic test for IBD, PredictSURE IBD™, launches in the UK and Ireland
PredictImmune's first prognostic test for IBD, PredictSURE IBD™, launches in the UK and Ireland The world's first validated prognostic test for inflammatory bowel disease (IBD) is now available via Cambridge University Hospitals NHS Foundation Trust's Genomic...
PredictImmune exhibiting at the 14th Congress of ECCO in Copenhagen, Denmark this March
PredictImmune exhibiting at the 14th Congress of ECCO in Copenhagen, Denmark this MarchCambridge, UK, 21st February 2019: Learn about the new and potential game-changing IBD prognostic tool, PredictSURE IBD™ at ECCO '19 this March in Copenhagen. You'll get a chance...
PredictImmune exhibiting and presenting poster at the 2019 Crohn's & Colitis Congress® in Las Vegas
PredictImmune exhibiting and presenting poster at the Crohn's & Colitis Congress® in Las Vegas Cambridge, UK, 17th January 2019: A great opportunity has arisen to meet PredictImmune's VP of Platform Discovery, Dr Paul Lyons, and discuss the latest data on its new...
PredictImmune co-founder to present T-Cell Exhaustion, Co-Stimulation and Clinical Outcome in Autoimmunity and Infection at Keystone Symposia, USA
PredictImmune co-founder to present T-Cell Exhaustion, Co-Stimulation and Clinical Outcome in Autoimmunity and Infection at Keystone Symposia, USA Cambridge, UK, 3rd January 2019: Professor Kenneth Smith, one of PredictImmune's founders and Head of the Department of...
PredictImmune's first prognostic test, PredictSURE IBD™, set for UK and European launch having been awarded CE mark
PredictImmune's first prognostic test, PredictSURE IBD™, set for UK and European launch having been awarded CE mark Achievement marks significant progress towards improving treatment and outcomes for IBD patients in the UK and Europe Cambridge, UK, December...
Crohn's Disease PROFILE Trial Protocol Published
Crohn's Disease PROFILE Trial Protocol Published PredictImmune is pleased to announce the e-publication of the PRedicting Outcomes For Crohn's dIsease using a moLecular biomarker (PROFILE) trial protocol in the BMJ. Cambridge, UK, 06 December 2018: The PROFILE...
PredictImmune joins the British In Vitro Device Association (BIVDA)
PredictImmune joins the British In vitro Device Association (BIVDA) Cambridge, UK, 13th November 2018: With the launch of its first product imminent, PredictImmune has joined the national IVD industry association to support its development as it continues to...